ZFIN ID: ZDB-PUB-181127-68
VANGL2 protein stability is regulated by integrin αv and the extracellular matrix
Jessen, T.N., Jessen, J.R.
Date: 2018
Source: Experimental cell research   374(1): 128-139 (Journal)
Registered Authors: Jessen, Jason R.
Keywords: VANGL2, adhesion, extracellular matrix, integrin αv, protein stability
MeSH Terms:
  • Animals
  • Cell Line, Tumor
  • Cell Membrane/metabolism
  • Cell-Matrix Junctions
  • Extracellular Matrix/metabolism*
  • Gene Knockdown Techniques
  • Green Fluorescent Proteins/metabolism
  • Integrin alphaV/metabolism*
  • Integrin beta Chains/metabolism
  • Integrin beta3/metabolism
  • Intracellular Signaling Peptides and Proteins/genetics
  • Intracellular Signaling Peptides and Proteins/metabolism*
  • Lysosomes/metabolism
  • Membrane Proteins/genetics
  • Membrane Proteins/metabolism*
  • Phenotype
  • Protein Stability
  • Proteolysis
  • Transcription, Genetic
  • Zebrafish
  • Zebrafish Proteins/metabolism*
PubMed: 30472097 Full text @ Exp. Cell Res.
FIGURES
ABSTRACT
Vang-like 2 (VANGL2) is a four-pass transmembrane protein required for a variety of polarized cell behaviors underlying embryonic development. Recent data show human VANGL2 interacts with integrin αv to control cell adhesion to extracellular matrix proteins. The goal of this study was to further define the functional relationship between integrin αv and VANGL2. We demonstrate integrin αv regulates VANGL2 protein levels both in vitro and in the zebrafish embryo. While integrin αv knockdown reduces VANGL2 expression at membrane compartments, it does not affect VANGL2 transcription. Knockdown of integrin β5, but not β1 or β3, also decreases VANGL2 protein levels. Inhibition of protein translation using cycloheximide demonstrates that integrin αv knockdown cells have increased VANGL2 degradation while interference with either proteasome or lysosome function restores VANGL2. We further show integrin activation and stimulation of cell-matrix adhesion using MnCl2 fails to influence VANGL2. However, MnCl2 treatment stabilizes VANGL2 protein expression levels in the presence of cycloheximide. In the converse experiment, blockage of integrin-mediated cell-matrix adhesion using a cyclic RGD peptide causes a reduction in VANGL2 protein levels. Together, our findings support a model where integrin αv and cellular interactions with the extracellular matrix are required to maintain VANGL2 protein levels and thus function at the plasma membrane.
ADDITIONAL INFORMATION